PHASE II, RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF PROSTVAC (PSA-TRICOM) IN PATIENTS... (PROTOCOL UAZ2012-03-01). CONTRACTOR: UNIVERSITY OF ARIZONA. CONTRACT: HHSN261201200031I. PERIOD: 9

NIH RePORTER · NIH · N01 · $168,543 · view on reporter.nih.gov ↗

Abstract

The contractor will conduct a phase II randomized, placebo-controlled, double-blind trial of PROSTVAC in patients with clinically localized prostate cancer undergoing active surveillance to assess the immunological (primary) and clinical (secondary) response to this vaccine.

Key facts

NIH application ID: 10207321
Project number: 261201200031I-P00007-26100006-1
Recipient: UNIVERSITY OF ARIZONA
Principal Investigator: SHERY CHOW
Activity code: N01
Funding institute: NIH
Fiscal year: 2020
Award amount: $168,543
Award type: —
Project period: 2014-09-12 → 2020-12-31